logo
UC Health, Blue Shield extend contract deadline, stave off disruption of care

UC Health, Blue Shield extend contract deadline, stave off disruption of care

UC Health and Blue Shield of California, which are at an impasse over the terms of a new contract that could disrupt health care for thousands of Californians, have extended the deadline for reaching a new agreement from July 9 to Aug. 9.
This means the thousands of Californians who get medical care at UC Health through Blue Shield of California — including many in the Bay Area who go to UCSF and One Medical, a UCSF affiliate — have an additional 30 days of breathing room before potentially having to find a different health insurer or pay out-of-network rates for services if UC Health and Blue Shield cannot reach a new contract.
UC Health and Blue Shield have been renegotiating contracts to establish how much Blue Shield will reimburse services provided by UC Health hospitals, clinics and other facilities. One Medical is an affiliate of UCSF Health, one of the six UC Health academic medical centers statewide.
Contract negotiations between health care providers and insurers are routine and often involve disagreements over reimbursement rates. In recent years, the tenor of such negotiations has grown more public and combative, often with each side accusing the other of taking positions that would ultimately harm consumers through higher prices or less accessible medical care.
Late last week, San Francisco City Attorney David Chiu and Supervisor Matt Dorsey waded into the matter, urging Blue Shield to finalize an agreement with UC Health so that the roughly 5,000 city employees and retirees who go to UCSF for medical care will not lose access to critical medical services.
Last year, UC Health and Anthem Blue Cross, another major insurer in California, similarly had a dispute over contract terms that lasted months. The two sides eventually reached a new contract.
In the Bay Area, the outcome of the negotiations between UC and Blue Shield could impact residents insured by Blue Shield who get care at UCSF Medical Center and UCSF Benioff Children's Hospitals in San Francisco and Oakland. It includes people in CalPERS plans, employer plans, Covered California plans and Medicare plans (including Medicare Advantage) offered or administered by Blue Shield.
The negotiations do not affect UCSF Health Community Hospitals at Saint Francis and St. Mary's, which will remain in-network.
Both UC Health and Blue Shield said Monday that they hope to reach a new agreement and avoid interruptions for their patients and members.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Civil Rights Icon Charles D. Neblett, PhD, Denied Critical Cancer Care Coverage Despite July 1 Medicare Policy Change
Civil Rights Icon Charles D. Neblett, PhD, Denied Critical Cancer Care Coverage Despite July 1 Medicare Policy Change

Associated Press

time9 hours ago

  • Associated Press

Civil Rights Icon Charles D. Neblett, PhD, Denied Critical Cancer Care Coverage Despite July 1 Medicare Policy Change

Denied Cancer Treatment Coverage Despite New Medicare Policy, Civil Rights Icon Inspires National Fundraiser as Black Prostate Check Challenge™ Enters Year Two 'Woke Up This Morning with My Mind Stayed on Freedom'—once a hymn, Neblett helped turn it into a civil rights rally cry. Facing the eve of Independence Day, his verse is medical, not metaphor.''— Charles D. Neblett, PhD. LOS ANGELES, CA, UNITED STATES, July 2, 2025 / / -- As the CMS Interoperability and Prior Authorization Final Rule took effect this week—requiring faster insurance decisions and electronic submissions—civil rights icon Dr. Charles D. Neblett is still waiting. The 84-year-old SNCC Freedom Singer, now battling stage 4 metastatic prostate cancer, has yet to receive approval for Promacta™, a critical platelet-stabilizing medication. Despite federal reforms and public pledges by insurers like Humana, Aetna, and UnitedHealthcare, delays persist. In Neblett's case, those delays may prove fatal. For over two months, Neblett has gone without Promacta™, and his platelet count has dropped to dangerously low threshold of irreversible damage that increases the risk of internal bleeding, hemorrhagic stroke, or trauma-induced death. The medication, which helps his bone marrow produce platelets, remains blocked by insurance even under the new CMS policy meant to prevent such life-threatening delays. Even as Medicare announces steps to improve prior authorization, Neblett warns: a pledge is not a protection. 'The same companies delaying my care now signed voluntary pledges back in 2018. If they meant it, I wouldn't be fighting for this medicine today.' 'Woke up this morning with my mind stayed on freedom.' It was a spiritual before it became a rallying cry—but reimagined for protest and mass meetings. Charles Neblett sang it through tear gas and jail bars as a founding member of the SNCC Freedom Singers. Facing the eve of Independence Day, he sings a different verse—one rooted in medical urgency, not metaphor. 'This isn't freedom,' Neblett says. 'Not if I'm fighting cancer while still battling for the medicine that keeps my blood from breaking down.' His concern is echoed by Black Prostate Check Challenge panelist™️ Dr. Clayton Yates, a John R. Lewis Professor of Pathology and Director of Translational Health Disparities Research at the Johns Hopkins School of Medicine. Dr. Yates affirms: 'Black men are more likely to experience low platelet counts during prostate cancer treatment—and if your platelets drop too low, your blood can't clot. That raises the risk of hemorrhagic stroke.' Johns Hopkins, where Yates leads multiple initiatives, is a global hub for prostate cancer research and care innovation. It was the birthplace of modern prostate cancer diagnostics and has developed leading surgical and clinical techniques used worldwide today. Its team includes one of the largest and most influential groups of prostate cancer clinicians and researchers, known for their work in urologic oncology, cancer genetics, and health equity. Yates's clinical findings on Black men and prostate cancer are regularly published and were recently featured in Nature Communications to demonstrate the link between inflammation-related immune responses and more lethal tumor profiles in Black men. These biological differences, combined with systemic insurance obstacles, help explain why mortality rates remain highest among Black prostate cancer patients. Still, Charles and his family face mounting uncertainty. His prescribed medication remains inaccessible. His condition, though stable, is fragile. And the new CMS rule, celebrated in national headlines, has yet to bring real relief. Marvinia Benton Neblett, Charles's wife of over 50 years and his full-time caregiver, underscores the urgency. 'This campaign is about visibility, yes—but also survival,' she says. 'Health equity means nothing if people can't access the medication their doctors prescribe. What does this say about how we treat our elders—especially in Black communities, where the combination of stroke and cancer is already too common?' Charles Neblett, Ph.D. was honored with the Pioneer of Justice Award by the NAACP Legal Defense Fund (#NEJAD2025), commemorating the 60th anniversary of Selma. The legacy of Dr. Charles D. Neblett inspired the Black Prostate Check Challenge™, a national campaign launched by NíCole Gipson of NGPR Strategic Communications exactly one year ago after Neblett announced his metastatic stage 4 cancer diagnosis. The campaign has now reached over 67 million people, sparking vital conversations across barbershops, newsrooms, and churches—helping shift public awareness and improve shared decision-making in Black men's healthcare. Now in Year Two, Gipson elevates the campaign—Black Prostate Check Challenge™️ into its second year, expanding beyond digital storytelling into structured platforms, including development of: • A children's book series focused on generational health and a biography of Dr. Neblett's legacy • A health equity docuseries, feature film — rooted in the real-life struggles and civil rights legacy of Charles • A podcast dedicated to patient voices and systemic change Gipson, founder of NGPR Strategic Communications, continues the blueprint for the campaign strategy in across multiple platforms and in coordination with legacy leaders, journalists, doctors, and grassroots organizers. 'My work has always centered on high-profile story telling—from ground breaking sitcoms to grassroots civil rights,' Gipson says. 'But this campaign expanded me into public service journalism with real stakes. It's not just storytelling—it's survival strategy.' As momentum builds, the team is entering a new phase. Doug Davis of Black Information Network co-created the campaign name and is shaping the next phase of multimedia expansion. 'This challenge is about real voices,' Davis says. 'We need media that shows what Black families go through while it's still happening—not after the fact.' This next phase of the campaign will also honor Charles Neblett's full legacy—from his earliest days marching with John Lewis and being jailed for nonviolent protest, to his current fight navigating the healthcare system as an elder, advocate, and grandfather. 'One wrong step, one untreated bleed, and it can be fatal,' Neblett says. 'That kind of fragility is hard to speak out loud—I've marched through tear gas and buried friends with stronger bodies than mine right now. But my faith and this campaign keep me going.' The urgency remains. A national fundraiser is now live to help Neblett access emergency Promacta™ doses and support BPCC 2.0. Every delay increases the risk. Every voice helps restore strength. HOW TO HELP: 🔗 📫 Checks payable to: Community Projects, Inc. (501c3) 571 E 7th Street Russellville, KY 42276 📞 Contact: Marvinia Benton Neblett – (270) 957-2836 Note to Editors: This release may be excerpted or reprinted with credit to NGPR Strategic Communications and the Black Prostate Check Challenge™. Media Relations Team NGPR Strategic Communications +1 314-824-8311 [email protected] Visit us on social media: LinkedIn Instagram Facebook YouTube TikTok X Other Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Jim Cramer gives his take on Centene's decline and the managed care sector
Jim Cramer gives his take on Centene's decline and the managed care sector

CNBC

time11 hours ago

  • CNBC

Jim Cramer gives his take on Centene's decline and the managed care sector

CNBC's Jim Cramer offered his take on healthcare company Centene and explained why he thinks the stock plummeted on Wednesday, telling investors to stay away from the sector as a whole. "Given this news from Centene, I think the whole managed care industry is borderline un-investable right now," he said. "And, unfortunately, things will get worse for this sector before they get better, so I just can't justify telling you to own these stocks right now, even after they've already come down so dramatically." Centene primarily provides healthcare exchanges for government programs like Medicaid and Medicare. Shares fell after it unexpectedly withdrew its full-year forecast Tuesday night. Management slashed earnings guidance, bringing adjusted diluted earnings per share down to $2.75 from the $7.25 estimate given during most recent quarter in April. The company cited data that shows lower overall market growth than expected in 22 of the 29 states it serves. The stock hit a new 52-week low, dropping down more than 40% by close, and the decline triggered losses across the group. According to Cramer, insurance providers broadly in the managed care space are having to pay out more than expected to cover policyholders' healthcare costs. He suggested that Centene's results indicate there is already some attrition in healthcare exchange enrollment, and that those still in these programs are less healthy than those who left. Centene's situation could become worse, Cramer said, as it will likely raise premiums to account for this new economic environment. Fewer people will enroll in healthcare programs if premiums go up, he continued, except for those with serious illnesses that are more expensive to treat. He also said Centene's earnings are liable to take another hit if market data from the rest of the states the company serves is disappointing. President Donald Trump's "big beautiful bill" does not bode well for Centene either, Cramer added. The Senate passed a version of the bill on Tuesday with sweeping new Medicaid policies that would substantially shrink Centene's customer base and leave millions of Americans without health insurance. Cramer noted that the bill also restricts fees that are imposed on healthcare providers to help fund Medicaid. Cramer said Centene is getting hit harder than some of its peers because much of its business is in the healthcare exchange space. But the company also faces other issues, he said, including higher costs for Medicaid plans, as well as higher costs for healthcare — which has been an industry-wide problem for a while. "At the end of the day, the news from Centene last night amounted to a very negative development for the company itself, but it's also just the latest in a long line of bad news for the health insurance cohort, a group that's already been having a really tough time," he said. Centene did not immediately respond to request for comment. Click here to download Jim Cramer's Guide to Investing at no cost to help you build long-term wealth and invest

What to Know About Medicare Coverage While Incarcerated
What to Know About Medicare Coverage While Incarcerated

Health Line

time13 hours ago

  • Health Line

What to Know About Medicare Coverage While Incarcerated

In some cases, incarceration may lead to disenrollment from your Medicare plan. However, there are special rules for reinstatement of coverage upon release. Incarcerated individuals and their families face unique challenges related to Medicare coverage. If you're enrolled in Medicare when you enter custody, you could be disenrolled from your plan if you miss premium payments or have a plan through a private insurance carrier. If you become eligible for Medicare while in custody, you may miss your Medicare initial enrollment period (IEP). For incarceration to affect your Medicare coverage, you need to be considered 'in the custody of penal authorities' by Medicare's definition. This includes being in jail, prison, or a mental health facility, as ordered by criminal law. This definition does not apply to people who are on parole, probation, or awaiting trial. Read on to learn how incarceration affects the different parts of Medicare, how to reenroll upon release, and more. Medicare while incarcerated overview Incarcerated individuals who are eligible for Medicare can maintain their Original Medicare (parts A and B) coverage while in custody. However, although you can maintain Original Medicare coverage during incarceration, Medicare will not pay for any services you receive. Rather, the penal institution where you're incarcerated will provide your healthcare. Additionally, you may enroll or reenroll in Medicare while in custody by contacting the Social Security Administration (SSA). Generally, you'll be automatically enrolled in Medicare if you turn 65 years old while receiving Social Security benefits. However, since Social Security benefits are discontinued while a person is in custody, you would need to enroll in Medicare manually during your IEP. Medicare coverage limitations while incarcerated Incarceration affects each part of Medicare in different ways. Part A If you're eligible for premium-free Part A while incarcerated, your coverage will continue throughout your time in custody. If you aren't eligible for premium-free Part A, you're entitled to enroll in Part A coverage while in custody. However, continued coverage is dependent on making monthly premium payments. If you cease paying the premium, you will be disenrolled from Part A. Part B To maintain Part B coverage while incarcerated, you'll have to continue paying the monthly premium. In 2025, the Part B premium starts at $185. If you stop paying it, Medicare will disenroll you from Part B. Medicare Advantage (Part C) To be eligible for a Medicare Advantage plan, you must live within the plan's service area. If you're incarcerated, you're considered outside the service area of Medicare Advantage. If you have a Medicare Advantage plan at the time of incarceration, you will be disenrolled from the plan. Part D Like Medicare Advantage plans, Part D plans are also offered by private insurance companies and vary based on a person's location. If you are in custody, you will be disenrolled from your Part D plan. Reinstating coverage upon release If you lose Medicare coverage while incarcerated or wish to switch your coverage, you can do so upon your release. Before 2023, if you were released from custody, you had to wait until the Medicare general enrollment period (GEP) to sign up for Medicare. This could result in months without Medicare coverage and potential late enrollment penalties. Since January 1, 2023, individuals released from custody qualify for an exceptional condition special enrollment period (SEP) for formerly incarcerated (in custody) individuals. This SEP begins the day of your release and ends on the last day of the 12th month after your release. If you miss the SEP for formerly incarcerated individuals, you'll need to wait until the next GEP to reenroll. After release, consider contacting the SSA to ask about signing up for Medicare. You can do so via phone at 800-772-1213 (TTY: 800-325-0778). Consequences of not reenrolling For Part A, Part B, and Part D, Medicare-eligible individuals can face late enrollment penalties for going without Medicare coverage. If you lose Medicare coverage while in custody and do not enroll during the SEP after your release, you may face penalties when you go to enroll at a later time. These penalties come in the form of higher monthly premium payments. Each penalty has a different calculation, but some can last for as long as you're enrolled. Frequently asked questions about Medicare while incarcerated What happens to Medicare when you are incarcerated? You can maintain your Original Medicare coverage while you're incarcerated if you continue paying any required premiums. If you have a Medicare Advantage (Part C) or Part D plan at the time of incarceration, you will be disenrolled when you enter custody, as the plan will consider you outside of its coverage area. You can reenroll in Medicare — or enroll for the first time, if you became eligible while incarcerated but missed your initial enrollment period — during a special enrollment period that begins when you're released. You can maintain your Original Medicare coverage while you're incarcerated if you continue paying any required premiums. If you have a Medicare Advantage (Part C) or Part D plan at the time of incarceration, you will be disenrolled when you enter custody, as the plan will consider you outside of its coverage area. You can reenroll in Medicare — or enroll for the first time, if you became eligible while incarcerated but missed your initial enrollment period — during a special enrollment period that begins when you're released. Do inmates get free healthcare in the United States? In the United States, incarcerated individuals have a right to adequate healthcare. However, this care is not always free. There may be fees, such as copayments, associated with different services or medications. In the United States, incarcerated individuals have a right to adequate healthcare. However, this care is not always free. There may be fees, such as copayments, associated with different services or medications. The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance products. Healthline Media does not transact the business of insurance in any manner and is not licensed as an insurance company or producer in any U.S. jurisdiction. Healthline Media does not recommend or endorse any third parties that may transact the business of insurance.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store